Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-7.23 Million ≈ $-1.06 Million USD) by net assets (CN¥2.30 Billion ≈ $336.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Tonghua Golden-Horse Pharmaceutical Indu balance sheet liabilities for a breakdown of total debt and financial obligations.
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jason Furniture(Hangzhou)
SHG:603816
|
0.072x |
|
Godrej Industries Limited
NSE:GODREJIND
|
-0.185x |
|
CIE Automotive S.A.
MC:CIE
|
0.329x |
|
Seek Ltd
AU:SEK
|
0.064x |
|
Jiangsu Aucksun Co Ltd
SHE:002245
|
0.038x |
|
Signet Jewelers Ltd
NYSE:SIG
|
0.018x |
|
CommVault Systems Inc
NASDAQ:CVLT
|
0.019x |
|
Pony AI Inc. American Depositary Shares
NASDAQ:PONY
|
-0.070x |
Annual Cash Flow Conversion Efficiency for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Tonghua Golden-Horse Pharmaceutical Indu worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.26 Billion ≈ $330.04 Million |
CN¥162.75 Million ≈ $23.81 Million |
0.072x | +48.32% |
| 2023-12-31 | CN¥2.32 Billion ≈ $339.21 Million |
CN¥112.78 Million ≈ $16.50 Million |
0.049x | -41.85% |
| 2022-12-31 | CN¥2.37 Billion ≈ $346.59 Million |
CN¥198.16 Million ≈ $29.00 Million |
0.084x | +41.49% |
| 2021-12-31 | CN¥2.34 Billion ≈ $342.31 Million |
CN¥138.33 Million ≈ $20.24 Million |
0.059x | +68.91% |
| 2020-12-31 | CN¥2.31 Billion ≈ $337.34 Million |
CN¥80.71 Million ≈ $11.81 Million |
0.035x | +24.67% |
| 2019-12-31 | CN¥2.67 Billion ≈ $390.12 Million |
CN¥74.86 Million ≈ $10.95 Million |
0.028x | -22.55% |
| 2018-12-31 | CN¥4.71 Billion ≈ $689.06 Million |
CN¥170.72 Million ≈ $24.98 Million |
0.036x | +506.01% |
| 2017-12-31 | CN¥4.42 Billion ≈ $646.57 Million |
CN¥26.43 Million ≈ $3.87 Million |
0.006x | -72.53% |
| 2016-12-31 | CN¥4.16 Billion ≈ $608.95 Million |
CN¥90.63 Million ≈ $13.26 Million |
0.022x | +130.40% |
| 2015-12-31 | CN¥2.25 Billion ≈ $328.72 Million |
CN¥-160.95 Million ≈ $-23.55 Million |
-0.072x | -237.69% |
| 2014-12-31 | CN¥659.50 Million ≈ $96.51 Million |
CN¥34.32 Million ≈ $5.02 Million |
0.052x | -68.91% |
| 2013-12-31 | CN¥615.08 Million ≈ $90.01 Million |
CN¥102.96 Million ≈ $15.07 Million |
0.167x | +1697.12% |
| 2012-12-31 | CN¥619.60 Million ≈ $90.67 Million |
CN¥-6.49 Million ≈ $-950.31K |
-0.010x | +19.78% |
| 2011-12-31 | CN¥607.13 Million ≈ $88.84 Million |
CN¥-7.93 Million ≈ $-1.16 Million |
-0.013x | -126.80% |
| 2010-12-31 | CN¥595.89 Million ≈ $87.20 Million |
CN¥29.05 Million ≈ $4.25 Million |
0.049x | -64.39% |
| 2009-12-31 | CN¥583.87 Million ≈ $85.44 Million |
CN¥79.94 Million ≈ $11.70 Million |
0.137x | +639.34% |
| 2008-12-31 | CN¥554.08 Million ≈ $81.08 Million |
CN¥10.26 Million ≈ $1.50 Million |
0.019x | -0.09% |
| 2007-12-31 | CN¥536.90 Million ≈ $78.57 Million |
CN¥9.95 Million ≈ $1.46 Million |
0.019x | +153.30% |
| 2006-12-31 | CN¥518.07 Million ≈ $75.81 Million |
CN¥-18.02 Million ≈ $-2.64 Million |
-0.035x | -104.40% |
| 2005-12-31 | CN¥45.26 Million ≈ $6.62 Million |
CN¥35.74 Million ≈ $5.23 Million |
0.790x | +51.26% |
| 2004-12-31 | CN¥36.64 Million ≈ $5.36 Million |
CN¥19.12 Million ≈ $2.80 Million |
0.522x | +68.00% |
| 2003-12-31 | CN¥296.07 Million ≈ $43.32 Million |
CN¥91.99 Million ≈ $13.46 Million |
0.311x | +109.74% |
| 2002-12-31 | CN¥490.79 Million ≈ $71.82 Million |
CN¥72.70 Million ≈ $10.64 Million |
0.148x | +109.51% |
| 2001-12-31 | CN¥475.05 Million ≈ $69.52 Million |
CN¥-740.34 Million ≈ $-108.34 Million |
-1.558x | -955.58% |
| 2000-12-31 | CN¥1.08 Billion ≈ $157.58 Million |
CN¥196.15 Million ≈ $28.70 Million |
0.182x | +336.55% |
| 1999-12-31 | CN¥1.05 Billion ≈ $153.20 Million |
CN¥-80.62 Million ≈ $-11.80 Million |
-0.077x | +22.07% |
| 1998-12-31 | CN¥636.82 Million ≈ $93.19 Million |
CN¥-62.93 Million ≈ $-9.21 Million |
-0.099x | -- |
About Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides… Read more